E-LIB Suche - Ergebnisse für: Deeg M.D., H.Joachim

1

Dose Rate-Dependent Sparing of the Gastrointestinal Tract b..:

Storb M.D., Rainer ; Raff M.H.S., PA-C, Robert ; Deeg M.D., H.Joachim...
International Journal of Radiation OncologyBiologyPhysics. 40 (1998) 4 - p. 961-966 , 1998

Link: https://doi.org/10.1016/..

2

Oral decitabine–cedazuridine versus intravenous decitabine ..:

Garcia-Manero, Guillermo ; McCloskey, James ; Griffiths, Elizabeth A...
The Lancet Haematology. 11 (2024) 1 - p. e15-e26 , 2024

Link: https://doi.org/10.1016/..

3

POSTER: MDS-634 Efficacy and Safety of Oral Decitabine/Ceda..:

Savona, Michael R. ; McCloskey, James K. ; Griffiths, Elizabeth A....
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S186 , 2023

Link: https://doi.org/10.1016/..

4

JAK2V617F mutation and associated chromosomal alterations i..:

Rafati, Maryam ; Brown, Derek W. ; Zhou, Weiyin...
Blood Advances. 7 (2023) 24 - p. 7506-7515 , 2023

Link: https://doi.org/10.1182/..

5

MDS-634 Efficacy and Safety of Oral Decitabine/Cedazuridine..:

Savona, Michael R. ; McCloskey, James K. ; Griffiths, Elizabeth A....
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S375-S376 , 2023

Link: https://doi.org/10.1016/..

6

P735: EFFICACY AND SAFETY OF ORAL DECITABINE/CEDAZURIDINE (..:

Robert Savona, Michael ; K Mccloskey, James ; A. Griffiths, Elizabeth...
HemaSphere. 7 (2023) S3 - p. e1342620 , 2023

Link: https://doi.org/10.1097/..

7

Association between Prior Cytotoxic Therapy, Antecedent Hem..:

Orvain, Corentin ; Rodríguez-Arbolí, Eduardo ; Othus, Megan...
Cancers. 15 (2023) 2 - p. 352 , 2023

Link: https://doi.org/10.3390/..

8

Whole-genome sequencing identifies novel predictors for hem..:

Zhang, Tao ; Auer, Paul ; Dong, Jing...
Journal of Hematology & Oncology. 16 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

9

Prognostic landscape of mitochondrial genome in myelodyspla..:

Dong, Jing ; Buradagunta, Christopher Staffi ; Zhang, Tao...
Journal of Hematology & Oncology. 16 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

10

Comparison of reduced intensity and nonmyeloablative condit..:

Walter, Roland B. ; Sandmaier, Brenda M. ; Othus, Megan...
Bone Marrow Transplantation. 58 (2022) 4 - p. 377-385 , 2022

Link: https://doi.org/10.1038/..

11

Contribution of measurable residual disease status to predi..:

Rodríguez-Arbolí, Eduardo ; Othus, Megan ; Orvain, Corentin...
Haematologica. 108 (2022) 1 - p. 273-277 , 2022

Link: https://doi.org/10.3324/..

12

Utility of the Treatment-Related Mortality (TRM) score to p..:

Zarling, Lucas C. ; Othus, Megan ; Sandmaier, Brenda M....
Leukemia. 36 (2022) 6 - p. 1563-1574 , 2022

Link: https://doi.org/10.1038/..

13

Germline-somatic JAK2 interactions are associated with clon..:

Brown, Derek W. ; Zhou, Weiyin ; Wang, Youjin...
Nature Communications. 13 (2022) 1 - p. , 2022

Link: https://doi.org/10.1038/..

14

Myeloablative versus Reduced-Intensity Conditioning for Hem..:

Scott, Bart L. ; Pasquini, Marcelo C. ; Fei, Mingwei...
Transplantation and Cellular Therapy. 27 (2021) 6 - p. 483.e1-483.e6 , 2021

Link: https://doi.org/10.1016/..

15

Phase I First-in-Human Dose Escalation Study of the oral SF..:

Steensma, David P. ; Wermke, Martin ; Klimek, Virginia M....
Leukemia. 35 (2021) 12 - p. 3542-3550 , 2021

Link: https://doi.org/10.1038/..